Complete the acquisition of Magellan Health

Delivered after the deadline (4 days after the deadline)

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced: 4 Jan 2021
Due: 31 Dec 2021
Delivered: 4 Jan 2022

Deadline
Met
Late
Not met
Today

What the company said

“Centene and Magellan Health expect to complete the transaction in the second half of 2021.”

SourceCentene Corporation Form 8-K press release, 2021-01-04
FilingSEC filing index
Deadline as statedin the second half of 2021
Deadline used31 Dec 2021, the last day of the stated period
TypeTransaction
Permanent referenceKI-C-2021-CNC-005469
Cite as https://keptindex.org/c/KI-C-2021-CNC-005469/ — this address never changes.

What we found

Evidence strength A What the grades mean

The filings show Centene completed the Magellan Health acquisition on January 4, 2022, a few days after the December 31, 2021 deadline.

A
Centene Corporation 10-K filed 2022-02-22 Regulatory filing · published 22 Feb 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC
“On January 4, 2022, we acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan) for a total purchase price of approximately $2.6 billion.” ✓ confirmed on the page
A
Centene Corporation 10-K filed 2022-02-22 Regulatory filing · published 22 Feb 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC
“On January 4, 2022, we acquired all of the issued and outstanding shares of Magellan Health.” ✓ confirmed on the page
A
Centene Corporation 10-Q filed 2022-04-26 Regulatory filing · published 26 Apr 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC
“On January 4, 2022, the Company acquired all of the issued and outstanding shares of Magellan.” ✓ confirmed on the page

Market reaction: the shares moved -0.1% against the S&P 500 over the three sessions around the disclosure (18 Feb 2022 to 24 Feb 2022). What this measures

Checked 10 Oct 2026.

Commitment lineage

Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.

1 versions

Version 1 · original · stated 4 Jan 2021

Deadline 31 Dec 2021 (“in the second half of 2021”) · wording expected
Version 2 · stated 27 Apr 2021

Deadline 31 Dec 2021 (“in the second half of 2021”) · wording firm

“the combination with Magellan remains on track to close in the second half of 2021”
Source for this version

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Acquisition close
Indicative materiality: High rules
Action: Complete
Deliverable: acquisition of Magellan Health
Language: Expected (“expects”, “plans”)
In the company’s control: Medium
Specificity: High
Conditional: Yes: clearance under the Hart-Scott Rodino Act; receipt of required state regulatory approvals; approval of the definitive merger agreement by Magellan Health’s stockholders
Depends on: Regulatory, Shareholder

How this entry was checked

Commitment recordedThe company's words were matched word for word against the filing.
First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Centene Corporation? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.